Patents by Inventor Caroline Dean

Caroline Dean has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8735173
    Abstract: A novel protein profiling method of testing for Lysosomal Storage Diseases (“LSD”) using discovered normalized lysosomal fingerprint patterns. The fingerprint patterns reveal the health of lysosomal organelles, specific LSD, and clinical severity. Multiplexing bead technology for simultaneous screening of multiple LSD and normalizing measured enzyme activity or protein levels against other lysosomal proteins, enzymes, or enzyme activities. Compounds, reagents, and methods for identifying and quantifying multiple target enzymes and proteins.
    Type: Grant
    Filed: March 28, 2012
    Date of Patent: May 27, 2014
    Assignee: Women's and Children's Hospital
    Inventors: Peter John Meikle, John Joseph Hopwood, Douglas Alexander Brooks, Caroline Dean
  • Publication number: 20120184050
    Abstract: A novel protein profiling method of testing for Lysosomal Storage Diseases (“LSD”) using discovered normalized lysosomal fingerprint patterns. The fingerprint patterns reveal the health of lysosomal organelles, specific LSD, and clinical severity. Multiplexing bead technology for simultaneous screening of multiple LSD and normalizing measured enzyme activity or protein levels against other lysosomal proteins, enzymes, or enzyme activities. Compounds, reagents, and methods for identifying and quantifying multiple target enzymes and proteins.
    Type: Application
    Filed: March 28, 2012
    Publication date: July 19, 2012
    Applicant: WOMEN'S AND CHILDREN'S HOSPITAL
    Inventors: Peter John Meikle, John Joseph Hopwood, Douglas Alexander Brooks, Caroline Dean
  • Patent number: 8173443
    Abstract: A novel protein profiling method of testing for Lysosomal Storage Diseases (“LSD”) using discovered normalized lysosomal fingerprint patterns. The fingerprint patterns reveal the health of lysosomal organelles, specific LSD, and clinical severity Multiplexing bead technology for simultaneous screening of multiple LSD and normalizing measured enzyme activity or protein levels against other lysosomal proteins, enzymes, or enzyme activities. Compounds, reagents, and methods for identifying and quantifying multiple target enzymes and proteins.
    Type: Grant
    Filed: March 31, 2004
    Date of Patent: May 8, 2012
    Assignee: Women's and Children's Hospital
    Inventors: Peter John Meikle, John Joseph Hopwood, Douglas Alexander Brooks, Caroline Dean
  • Patent number: 7615224
    Abstract: Multiplexing bead technology is used for simultaneous screening of multiple LSD and normalizing measured enzyme activity or protein levels against other lysosomal proteins, enzymes, or enzyme activities. Diagnostic compositions include microspheres conjugated to purified antibodies that specifically bind LSD target antigens: saposin, LAMP-1, ?-iduronidase, ?-glucosidase, ?-glucosidase, 2-sulphatase, 4-sulphatase, ?-galactosidase, sphingomyelinase, 3-sulphatase or sulphamidase. The target antigens are naturally present in biological fluids or tissues of either LSD or non-LSD patients.
    Type: Grant
    Filed: December 1, 2005
    Date of Patent: November 10, 2009
    Assignee: Women's and Children's Hospital
    Inventors: Peter John Meikle, John Joseph Hopwood, Douglas Alexander Brooks, Caroline Dean
  • Publication number: 20070265432
    Abstract: Multiplexing bead technology is used for simultaneous screening of multiple LSD and normalizing measured enzyme activity or protein levels against other lysosomal proteins, enzymes, or enzyme activities. Diagnostic compositions include microspheres conjugated to purified antibodies that specifically bind LSD target antigens: saposin, LAMP-1, ?-iduronidase, ?-glucosidase, ?-glucosidase, 2-sulphatase, 4-sulphatase, ?-galactosidase, sphingomyelinase, 3-sulphatase or sulphamidase. The target antigens are naturally present in biological fluids or tissues of either LSD or non-LSD patients.
    Type: Application
    Filed: December 1, 2005
    Publication date: November 15, 2007
    Applicant: Women's and Children's Hospital
    Inventors: Peter Meikle, John Hopwood, Douglas Brooks, Caroline Dean
  • Patent number: 7253274
    Abstract: An isolated nucleic acid obtainable from the VRN2 locus of a plant, which nucleic acid encodes a polypeptide which is capable of affecting one or more physical characteristics of a plant into which the nucleic acid is introduced, the physical characteristics being selected from vernalization response, flowering time, leaf size, and/or shape or shade avoidance response; alleles, fragment and derivatives thereof; polypeptides encoded by such nucleic acids; antibodies to such peptides.
    Type: Grant
    Filed: September 16, 2004
    Date of Patent: August 7, 2007
    Assignee: Pioneer Hi-Bred International
    Inventors: Caroline Dean, Anthony Gendall
  • Patent number: 7230158
    Abstract: Disclosed are isolated nucleic acids obtainable from the FRI locus of plants which encode polypeptides capable of specifically altering, particularly delaying, the flowering time of a plant into which the nucleic acid is introduced. One preferred embodiment is the FRI nucleotide sequence which encodes the polypeptide of FIG. 6 (see the sequence of FIG. 5, particularly bases 362-2188 thereof) or sequences degeneratively equivalent to these. Also provided are variant sequences (e.g. alleles, orthologues, derivatives) and complementary sequences, plus vectors, host cells, plants and associated processes of production and methods of use e.g. for influencing or affecting flowering time in a plant by expression or suppression of FRI or variant sequences.
    Type: Grant
    Filed: July 19, 2004
    Date of Patent: June 12, 2007
    Assignee: Pioneer High-Bred International, Inc.
    Inventors: Urban Johanson, Joanne West, Caroline Dean
  • Publication number: 20070072243
    Abstract: A novel protein profiling method of testing for Lysosomal Storage Diseases (“LSD”) using discovered normalized lysosomal fingerprint patterns. The fingerprint patterns reveal the health of lysosomal organelles, specific LSD, and clinical severity Multiplexing bead technology for simultaneous screening of multiple LSD and normalizing measured enzyme activity or protein levels against other lysosomal proteins, enzymes, or enzyme activities. Compounds, reagents, and methods for identifying and quantifying multiple target enzymes and proteins.
    Type: Application
    Filed: March 31, 2004
    Publication date: March 29, 2007
    Inventors: Peter Meikle, John Hopwood, Douglas Brooks, Caroline Dean
  • Patent number: 7045682
    Abstract: Provided are isolated nucleic acid molecules which comprise VRN1 nucleotide sequences, which encode a polypeptide which is capable of specifically altering the vernalisation response of a plant into which the nucleic acid is introduced and expressed. Examples include cDNA and gDNA sequences (see e.g., Annex I). Also provided are variant molecules which may be derivatives or homologues (e.g., alleles, or paralogues such as RTV1), plus also complementary molecules. Corresponding polypeptides form a further part of the invention. The invention also provides methods and materials for preparing and using these molecules, e.g., in the production of plants having modified vernalisation characteristics. Also provided are methods for influencing and assessing the vernalisation phenotype of a plant.
    Type: Grant
    Filed: September 13, 2000
    Date of Patent: May 16, 2006
    Assignee: Pioneer Hi-Bred International
    Inventors: Caroline Dean, Yaron Yakov Levy
  • Patent number: 6949694
    Abstract: The invention discloses nucleic acid encoding an FY polypeptide with the sequence shown in Annex 2. Also provided are vectors, host cells and plants. Methods of the invention include the use of nucleic acids to express or down-regulate FY in plants. The methods may be used to affect flowering time or juvenile phase length in plants.
    Type: Grant
    Filed: July 11, 2002
    Date of Patent: September 27, 2005
    Assignee: Pioneer Hi-Bred International, Inc.
    Inventors: Gordon Grant Simpson, Caroline Dean, Paul Dijkwel
  • Publication number: 20050132446
    Abstract: An isolated nucleic acid obtainable from the VRN2 locus of a plant, which nucleic acid encodes a polypeptide which is capable of affecting one or more physical characteristics of a plant into which the nucleic acid is introduced, the physical characteristics being selected from vernalization response, flowering time, leaf size, and/or shape or shade avoidance response; alleles, fragment and derivatives thereof; polypeptides encoded by such nucleic acids; antibodies to such peptides.
    Type: Application
    Filed: September 16, 2004
    Publication date: June 16, 2005
    Inventors: Caroline Dean, Anthony Gendall
  • Publication number: 20050060774
    Abstract: Disclosed are isolated nucleic acids obtainable from the FRI locus of plants which encode polypeptides capable of specifically altering, particularly delaying, the flowering time of a plant into which the nucleic acid is introduced. One preferred embodiment is the FRI nucleotide sequence which encodes the polypeptide of FIG. 6 (see the sequence of FIG. 5, particularly bases 362-2188 thereof) or sequences degeneratively equivalent to these. Also provided are variant sequences (e.g. alleles, orthologues, derivatives) and complementary sequences, plus vectors, host cells, plants and associated processes of production and methods of use e.g. for influencing or affecting flowering time in a plant by expression or suppression of FRI or variant sequences.
    Type: Application
    Filed: July 19, 2004
    Publication date: March 17, 2005
    Inventors: Urban Johanson, Joanne West, Caroline Dean
  • Publication number: 20030084483
    Abstract: The invention discloses nucleic acid encoding an FY polypeptide with the sequence shown in Annex 2. Also provided are vectors, host cells and plants. Methods of the invention include the use of nucleic acids to express or down-regulate FY in plants. The methods may be used to affect flowering time or juvenile phase length in plants.
    Type: Application
    Filed: July 11, 2002
    Publication date: May 1, 2003
    Inventors: Gordon Grant Simpson, Caroline Dean, Paul Pieter Dijkwel
  • Patent number: 6140085
    Abstract: FCA genes of Arabidopsis thaliana and Brassica napus are provided, enabling flowering characteristics, particularly timing of flowering, to be influenced in transgenic plants. Timing of flowering may be delayed or hastened using sense and antisense expression, also various mutants and alleles, including alternatively spliced forms.
    Type: Grant
    Filed: December 1, 1997
    Date of Patent: October 31, 2000
    Assignee: Plant BioScience Limited
    Inventors: Caroline Dean, Richard Colin Macknight, Ian Bancroft, Clare Katharine Lister
  • Patent number: 5349127
    Abstract: DNA sequences encoding herbicide metabolizing cytochrome P450 enzymes and iron-sulfur proteins that donate electrons to these enzymes, were introduced into plants and microorganisms rendering them able to produce the encoded gene products and to metabolize herbicides.
    Type: Grant
    Filed: October 26, 1992
    Date of Patent: September 20, 1994
    Assignee: E. I. Du Pont de Nemours and Company
    Inventors: Caroline Dean, Patricia A. Harder, Kenneth J. Leto, Daniel P. O'Keefe, Charles A. Omer, James A. Romesser, James M. Tepperman
  • Patent number: 5212296
    Abstract: DNA sequences encoding herbicide metabolizing cytochrome P450 enzymes and iron-sulfur proteins that donate electrons to these enzymes, were introduced into plants and microorganisms rendering them able to produce the encoded gene products and to metabolize herbicides.
    Type: Grant
    Filed: August 23, 1990
    Date of Patent: May 18, 1993
    Assignee: E. I. Du Pont de Nemours and Company
    Inventors: Caroline Dean, Patricia A. Harder, Kenneth J. Leto, Daniel P. O'Keefe, Charles A. Omer, James A. Romesser, James M. Tepperman
  • Patent number: 4962028
    Abstract: Promoter sequences from the gene from the small subunit of ribulose-1,5-bisphosphate carboxylase are disclosed. Expression cassettes containing a promoter sequence, a linker region, and a 3' fragment are also disclosed. The promotor sequences and expression cassettes are useful for expressing foreign genes to high levels in transformed plants.
    Type: Grant
    Filed: July 9, 1986
    Date of Patent: October 9, 1990
    Assignee: DNA Plant Technology Corporation
    Inventors: John R. Bedbrook, Caroline Dean, Pamela Dunsmuir